about
Identification of Critical Residues in G 13 for Stimulation of p115RhoGEF Activity and the Structure of the G 13-p115RhoGEF Regulator of G Protein Signaling Homology (RH) Domain ComplexModification of p115RhoGEF Ser(330) regulates its RhoGEF activity.Cancer Cell Invasion in Three-dimensional Collagen Is Regulated Differentially by Gα13 Protein and Discoidin Domain Receptor 1-Par3 Protein SignalingInteraction of tRNA with MEK2 in pancreatic cancer cellsDifferential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer.GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1.Snail cooperates with Kras G12D in vivo to increase stem cell factor and enhance mast cell infiltration.BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasiaMinimal Physiologically Based Pharmacokinetic and Drug-Drug-Disease Interaction Model of Rivaroxaban and Verapamil in Healthy and Renally Impaired Subjects.Impaired Rivaroxaban Clearance in Mild Renal Insufficiency With Verapamil Coadministration: Potential Implications for Bleeding Risk and Dose Selection.Vortioxetine Disposition in Obesity: Potential Implications for Patient Safety.Quantitative Method to Track Proteolytic Invasion in 3D CollagenPersistence of a Posaconazole-Mediated Drug-Drug Interaction With Ranolazine After Cessation of Posaconazole Administration: Impact of Obesity and Implications for Patient SafetySustained Impairment of Lurasidone Clearance After Discontinuation of Posaconazole: Impact of Obesity, and Implications for Patient SafetyHLA associations with infliximab-induced liver injury
P50
Q27667495-0F2AC043-A2A0-4871-9081-9EEEEB9C3952Q33827760-B8DDF30B-2588-4855-8BD7-7570331BB301Q36489242-8CC79C07-AC0C-4DBD-9747-BC4EFA2E24FAQ37006130-568978A4-36C9-47D0-BB6D-74187A8B4FE3Q38514906-57A6C1C6-9770-44E4-B159-DA7A11891523Q38895410-69DDA43C-68FC-44A9-93DA-064B8AC646EAQ38983127-8BBDBFE4-6E29-4F5D-95EE-ECF26E838DA3Q42128109-4F0A4804-1D78-41AC-A6DD-795AEABBE847Q42457687-BAB9B858-FFDC-43FA-B5FA-440561D7B1BDQ47313037-6FD288FA-9037-4BE6-80CD-DB1BBCCE043FQ50193651-24DB619B-D930-47A9-ABCA-CE6361043746Q52622443-E22985EB-3C36-4155-A711-3B37ACB17481Q58075504-B6E9959E-ABAA-48F4-B412-E0A65F25D46EQ88637263-B6369EAF-F9AE-477C-A588-25A6336F90FEQ88932849-80C4A77E-D7EA-427D-A10A-5AD55F9DCCD7Q89556419-48C4E10E-F21E-4F7C-9DD5-5EF91C3D6438
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Christina R Chow
@ast
Christina R Chow
@en
Christina R Chow
@es
Christina R Chow
@nl
Christina R Chow
@sl
type
label
Christina R Chow
@ast
Christina R Chow
@en
Christina R Chow
@es
Christina R Chow
@nl
Christina R Chow
@sl
prefLabel
Christina R Chow
@ast
Christina R Chow
@en
Christina R Chow
@es
Christina R Chow
@nl
Christina R Chow
@sl
P106
P21
P31
P496
0000-0003-3944-4234